Search Results - Gilmore, G.T.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Multinuclear NMR and UV–Vis spectroscopy of site directed mutants of the diabetes drug target protein mitoNEET suggest that folding is intimately coupled to iron–sulfur cluster formation

    Multinuclear NMR and UV–Vis spectroscopy of site directed mutants of the diabetes drug target protein mitoNEET suggest that folding is intimately coupled to iron–sulfur cluster for... by Benson, S.K., Boyce, K.M., Bunker, R.M., Collins, N.B., Daily, K.J., Esway, A.S., Gilmore, G.T., Hartzler, C.W., Howard, G.P., Kasmar, N.A., Kennedy, K.J., King, B.L., Kordahi, T.N., Mattioli, T.A., Pugh, D.M., Ray, L.A., Ross, S.L., Torcasio, M.H., Webber, D.P., Morris, D.L., Leeper, T.C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model

    Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model by Gilmore, S, Tam, D, Dick, R, Appleby, T, Birkus, G, Willkom, M, Delaney, W.E, Notte, G.T, Feierbach, B

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus

    In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus by Gilmore, S.A, Snyder, C.A, Dick, R, Matles, M, Tam, D, Tay, C.H, Farand, J, Paoli, E, Delaney, W.E, Feierbach, B, Notte, G.T

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    SAT-160 - Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model

    SAT-160 - Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model by Gilmore, S., Tam, D., Dick, R., Appleby, T., Birkus, G., Willkom, M., Delaney, W.E., Notte, G.T., Feierbach, B.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    THU-171 - In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus

    THU-171 - In vivo pharmacodynamics of GS-5801, a liver targeted prodrug of a lysine demethylase 5 inhibitor with antiviral activity against hepatitis B virus by Gilmore, S.A., Snyder, C.A., Dick, R., Matles, M., Tam, D., Tay, C.H., Farand, J., Paoli, E., Delaney, W.E., Feierbach, B., Notte, G.T.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: